✍️ Trichometrics Editorial Team·🩺 Reviewed for medical accuracy
For informational purposes only — consult a healthcare provider before starting treatment.
FDA-Approved Treatment

Finasteride for Hair Loss: Complete Guide & Results

Finasteride is the most widely prescribed oral medication for male pattern hair loss. Here's what the clinical research says about how it works, what results to expect, and what to watch out for.

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any treatment. Individual results may vary.

How Finasteride Works

Finasteride inhibits Type II 5-alpha reductase, the enzyme responsible for converting testosterone into dihydrotestosterone (DHT). By blocking this conversion, finasteride reduces serum DHT levels by approximately 70% (Kaufman et al., Journal of the American Academy of Dermatology, 1998).

DHT is the primary androgen responsible for miniaturizing hair follicles in genetically susceptible individuals. Over time, DHT causes terminal hairs to become progressively thinner and shorter (vellus hairs) until the follicle stops producing visible hair entirely. This process is known as follicular miniaturization and is the hallmark of androgenetic alopecia.

By reducing DHT levels, finasteride slows or halts this miniaturization process. In many cases, partially miniaturized follicles can recover and begin producing thicker, terminal hairs again, which is why regrowth (not just maintenance) is possible.

Clinical Results by Timeline

Finasteride is not an overnight solution. Here's what clinical data and real-world experience show you can expect month by month.

Month 1-3

DHT Suppression & Shedding Phase

Serum DHT levels drop by ~70% within weeks. Some men experience temporary increased shedding as weakened hairs are pushed out by new growth. This is a normal sign the medication is working.

Month 3-6

Shedding Slows, Early Regrowth

Shedding subsides. Follicles previously miniaturized by DHT begin producing thicker, terminal hairs. Subtle improvements in hair density may become noticeable, particularly at the crown.

Month 6-12

Visible Thickening & Regrowth

Most men see meaningful cosmetic improvement. Hair count increases, existing hairs thicken, and previously thinning areas begin to fill in. Photos taken at this stage often show clear differences from baseline.

Month 12-24

Maximum Results Achieved

Peak regrowth is typically reached by 12-24 months of consistent use. The 5-year data from the landmark Kaufman study showed continued maintenance of hair count. Ongoing use is required to maintain results.

Effectiveness Statistics

Key findings from peer-reviewed clinical studies on finasteride for androgenetic alopecia.

83%

of men maintained their hair count over 2 years of treatment

Kaufman et al., Journal of the American Academy of Dermatology, 1998

66%

of men showed visible hair regrowth at the 2-year mark

Kaufman et al., JAAD, 1998

Superior

results when combined with minoxidil vs. either treatment alone

Hu et al., Journal of the American Academy of Dermatology, 2015

Side Effects & Safety

An honest, balanced look at finasteride's safety profile based on clinical trial data.

Common Side Effects (~2%)

  • --Reduced libido (1.8% vs 1.3% placebo in clinical trials)
  • --Erectile dysfunction (1.3% vs 0.7% placebo)
  • --Decreased ejaculate volume (0.8% vs 0.4% placebo)

These rates are from the original Merck clinical trials (n=1,553). The difference between drug and placebo groups was small, and side effects resolved in the majority of men who continued treatment.

Rare & Discussed Concerns

  • --Breast tenderness or gynecomastia (rare, <1%)
  • --Mood changes, including depression or anxiety (reported anecdotally; causal link debated)

A 2012 study in the Journal of Sexual Medicine found that side effects resolved in 97% of men who discontinued the medication. Some users report persistent effects after stopping (post-finasteride syndrome). While the mechanism is debated in the medical literature, it is important to discuss any concerns with your doctor before starting or stopping treatment.

Track Your Finasteride Results

Taking finasteride? Track your progress with AI-powered photo analysis. See exactly how your hair is responding over weeks and months, no more guessing.

Track My Finasteride Progress

Frequently Asked Questions

What is the standard dosage of finasteride for hair loss?

The FDA-approved dosage for male pattern hair loss is 1mg per day (brand name Propecia). This is significantly lower than the 5mg dose used for prostate conditions (Proscar). Some dermatologists prescribe alternate-day dosing or lower doses (0.5mg) for patients who experience side effects, though this is off-label. Consistency is key, finasteride must be taken daily for optimal results.

How long do I need to take finasteride?

Finasteride must be taken continuously to maintain results. If you stop taking it, DHT levels return to baseline within about 2 weeks, and any hair gained will gradually be lost over 6-12 months. The 10-year follow-up data from the original clinical trials showed that men who continued treatment maintained their results long-term, while those who stopped experienced progressive loss.

Is topical finasteride effective compared to oral?

Topical finasteride (typically 0.1-0.25%) has gained popularity as a way to reduce systemic exposure while still lowering scalp DHT. A 2022 study in the Journal of the American Academy of Dermatology by Piraccini et al. found that topical finasteride 0.25% reduced scalp DHT comparably to oral 1mg while producing significantly lower serum DHT reduction. This may reduce the risk of systemic side effects, though long-term data is more limited than for oral finasteride.

Can women use finasteride for hair loss?

Finasteride is not FDA-approved for women and is contraindicated in women who are or may become pregnant due to the risk of birth defects in male fetuses. However, some dermatologists prescribe it off-label for postmenopausal women with androgenetic alopecia. A 2018 review in the Journal of the American Academy of Dermatology noted mixed results in premenopausal women. Women considering finasteride should discuss the risks and benefits with their doctor thoroughly.